Implantology in patients affected by systemic diseases and on polypharmacy

被引:0
|
作者
Morelli, Chiara [1 ]
Salerno, Eleonora [1 ]
Pispero, Alberto [2 ]
Franchini, Roberto [2 ]
Lombardi, Niccolo [2 ]
机构
[1] Univ Milan, Dipartimento Sci Biomed Chirurg & Odontoiatr, Milan, Italy
[2] Univ Milan, ASST Santi Paolo & Carlo, Osped San Paolo, SC Odontostomatol 2,Dipartimento Sci Biomed Chiru, Milan, Italy
关键词
Polypharmacy; Systemic diseases; Implantology; Implant success; Implant complications; SEROTONIN REUPTAKE INHIBITORS; DENTAL IMPLANTS; MEDICATIONS; SURGERY; RISK; OSSEOINTEGRATION; PLACEMENT; SURVIVAL; OUTCOMES; IMPACT;
D O I
10.19256/d.cadmos.04.2022.05
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
OBJECTIVES The progressive increase in age in the general population, in the European Union and in particular in Italy, is necessarily leading dentists to interface with patients affected by multiple concomitant systemic diseases. These patients, who often are in polytherapy, increasingly require implant-prosthetic rehabilitation for their total or partial edentulousness. In these patients, prosthetic rehabilitation takes on an important significance, in order to guarantee a better quality of life and a re-appropriation of fundamental actions for social and psychological well-being such as eating, talking and smiling. Therefore, a careful study of the patient's medical history helps to minimize intra- and post-operative complications. The objective of this manuscript is to describe the relationship between systemic diseases, drug therapies and the decision-making process, as well as surgical rehabilitation, which every specialist must evaluate interfacing with a patient affected by systemic diseases and in drug polytherapy. MATERIALS AND METHODS This review emphasizes the importance of the patient's general health and the impact of drug therapies on implant rehabilitation. It is important to consider how some medical conditions can increase the risk of treatment failure or increase the risk of post-operative complications. Recent research of the scientific literature was carried out to guarantee, on the basis of up-to-date clinical data, useful advice to deal with the most common diseases and with their pharmacological therapies. Drug interactions in patients undergoing systemic polytherapy represent a problem which is difficult to manage even by healthcare professionals; therefore, adequate knowledge about drug therapies is a conditio sine qua non for a reliable implant rehabilitation surgery. CONCLUSIONS Polytherapy is crucial for the dentist who intends to deal with a patient with multiple systemic diseases and the continuous research, through the use of recent sources, allows to build a complete picture of the risk factors, the relative and absolute contraindications for this kind of rehabilitation, so as to reduce the risk of intra- and post-operative complications. In addition, the evaluation of the patients' medical condition ensures higher percentage of success and survival implant rate. CLINICAL SIGNIFICANCE It is imperative, in a population that has a high life expectancy and with an increasing incidence of chronic diseases, that the dentist is ready to deal with these patients with extreme accuracy. Scientific evidence is an important source that each dentist should analyze treating patients undergoing polytherapy to ensure the most predictable result. The knowledge on drug therapies and patient systemic diseases reduces the risk of errors and disputes in the community of dental practitioners; for this reason, each specialist should strive to acquire an education based on international scientific literature.
引用
收藏
页码:274 / 287
页数:14
相关论文
共 50 条
  • [1] Polypharmacy in Patients with Ovarian Cancer
    Oldak, Sean
    Ioannou, Stephanie
    Kamath, Priyanka
    Huang, Marilyn
    George, Sophia
    Slomovitz, Brian
    Schlumbrecht, Matthew
    ONCOLOGIST, 2019, 24 (09): : 1201 - 1208
  • [2] Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy
    Rieckert, Anja
    Trampisch, Ulrike S.
    Klaassen-Mielke, Renate
    Drewelow, Eva
    Esmail, Aneez
    Johansson, Tim
    Keller, Sophie
    Kunnamo, Ilkka
    Loeffler, Christin
    Makinen, Joonas
    Piccoliori, Giuliano
    Vogele, Anna
    Soennichsen, Andreas
    BMC FAMILY PRACTICE, 2018, 19
  • [3] Polypharmacy prior to in-hospital cardiac arrest among patients with cardiopulmonary diseases: A pilot study
    Attin, Mina
    Abiola, Simeon
    Magu, Rijul
    Rosero, Spencer
    Apostolakos, Michael
    Groth, Christine M.
    Block, Robert
    Lin, C. D.
    Intrator, Orna
    Hurley, Deborah
    Arcoleo, Kimberly
    RESUSCITATION PLUS, 2020, 4
  • [4] Frailty and Polypharmacy in Older Patients with Otolaryngologic Diseases
    Eibling, David
    CLINICS IN GERIATRIC MEDICINE, 2018, 34 (02) : 289 - +
  • [5] Polypharmacy With Common Diseases in Hospitalized Elderly Patients
    Mizokami, Fumihiro
    Koide, Yumiko
    Noro, Takeshi
    Furuta, Katsunori
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2012, 10 (02): : 123 - 128
  • [6] Local and systemic light chain amyloidosis in patients with rheumatic diseases
    Veelken, K.
    Hegenbart, U.
    Schoenland, S. O.
    Blank, N.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (07): : 660 - 667
  • [7] Polypharmacy among patients admitted to hospital with rheumatic diseases
    Kirsten K. Viktil
    Merethe Enstad
    Janne Kutschera
    Liv Marit Smedstad
    Jan Schjott
    Pharmacy World and Science, 2001, 23 : 153 - 158
  • [8] Polypharmacy among patients admitted to hospital with rheumatic diseases
    Viktil, KK
    Enstad, M
    Kutschera, J
    Smedstad, LM
    Schjott, J
    PHARMACY WORLD & SCIENCE, 2001, 23 (04): : 153 - 158
  • [9] Polypharmacy and enteral nutrition in patients with complex chronic diseases
    Romero Jimenez, Rosa Ma.
    Ortega Navarro, Cristina
    Cuerda Compes, Cristina
    NUTRICION HOSPITALARIA, 2017, 34 : 57 - 76
  • [10] Effects of Polypharmacy in Elderly Diabetic Patients: A Review
    Kumari, Sweta
    Jain, Shraddha
    Kumar, Sunil
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)